Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiac potassium channels are membrane-spanning proteins that facilitate the passive movement of potassium ions (K⁺) across the cardiac cell membrane, following their electrochemical gradient. These channels play a central role in regulating the resting membrane potential, determining pacemaker cell frequency, and shaping both the duration and morphology of the cardiac action potential. Their coordinated activity is essential for normal heart rhythm and adaptation to physiological demands. Dysfunction or mutations in these channels can lead to arrhythmias. They are major drug targets for antiarrhythmic therapies.
Blockage or opening of potassium channels to modulate cardiac action potential duration and repolarization.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel protein (various cardiac potassium currents).